PPARG and Insulin resistance: 2011; Minghetti et al. 2014; Quintanilla et al. 2014). Preterm birth is associated with an increased cardiometabolic disease risk in adulthood (Ryckman et al. 2013; Bayman et al. 2014; Kajantie and Hovi 2014), and PPAR‐gamma agonists (thiazolidinediones) are widely used in the treatment of Type 2 Diabetes Mellitus (T2DM) and insulin resistance.